Chole Timothy 4

What Happened
Chole Timothy, Senior Vice President and Chief Commercial Officer of Rockwell Medical, was granted 15,000 restricted stock units (RSUs) on July 1, 2026. The RSUs are reported at $0.00 at grant (no cash purchase), and they vest in three equal installments on the first, second and third anniversaries of July 1, 2026 (i.e., July 1 of 2027, 2028 and 2029), subject to continued service.

Key Details

• Transaction date: July 1, 2026; reported on Form 4 filed July 6, 2026.
• Transaction type: Award/Grant (code A) — 15,000 RSUs; reported acquisition price $0.00.
• Vesting: Three equal annual installments on the 1st, 2nd and 3rd anniversaries of July 1, 2026 (service-based).
• Corporate action: A 1-for-10 reverse stock split was effective at 12:01 AM on July 1, 2026; outstanding equity awards (including these RSUs) and reported share figures were proportionately adjusted.
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• Timeliness: Form 4 was filed July 6 for a July 1 transaction — this appears to be later than the typical two-business-day filing requirement for Form 4s.

Context

• This was an equity award (RSUs), not a cash purchase or sale; RSUs typically deliver shares (or value) only as they vest and subject to service conditions.
• Awards like this are common compensation for senior executives and do not by themselves indicate a buy or sell decision in the market.
• The reverse split reduced the reported share counts across the company and adjusted outstanding awards proportionally; the grant amount shown here already reflects that adjustment.